4D Molecular Therapeutics, Inc.(FDMT)
NASDAQ
$13.10
0.81 (6.59%)

4D Molecular Therapeutics, Inc.(FDMT)Fundamental Analysis & Financials
NASDAQ

Valuation Snapshot

What the multiples imply about expectations

The market considers the company to be a smaller player with a significant market presence. At current multiples, it trades fairly valued—reflecting market expectations.

Valuation Metrics

Ratios and multiples

EV/Revenue (TTM)4.36

Financial Health

Liquidity and leverage

ROE (TTM)-43.25%
ROA (TTM)-25.09%
Debt/Equity (MRQ)0.10

The company's financial health appears moderate. Moderate ROE and moderate ROA reflect reasonably efficient capital use. Debt is manageable within acceptable ranges.

Valuation Multiples

Current valuation metrics

P/B Ratio1.77
P/S Ratio7.87

Quarterly Earnings History

Recent quarterly financial performance and trends

Latest Quarter
Q2 2026
Revenue
$3.78M
Net Income
-$72.94M
EPS (Diluted)
-$1.04
QuarterRevenueNet IncomeGross ProfitEPS (Basic)EPS (Diluted)Gross MarginNet Margin
Q2 2026(Latest)$3.78M-$72.94MN/A-$1.04-$1.04N/A-1929.0%
Q1 2026$3.05M-$68.76MN/A-$1.01-$1.01N/A-2256.7%
Q4 2025$85.09M$19.40MN/AN/AN/AN/A22.8%
Q3 2025$90.00K-$56.88MN/A-$1.01-$1.01N/A-63195.6%
Q2 2025$15.00K-$54.66MN/A-$0.98-$0.98N/A-364386.7%

Key Insights:

  • Revenue increased by 24.1% from previous quarter
  • Net margin of -1929.0% indicates low profitability
  • EPS declined by 3.0% quarter-over-quarter

Financial Efficiency

Utilization and collections performance

Asset Turnover 0.16 indicates low efficiency. Working Capital Turnover 0.25 is moderately efficient. ROIC -35.4% highlights weak capital returns.

Efficiency Metrics

Asset Turnover0.16
Working Capital Turnover0.25
ROIC (TTM)-35.4%

Profitability & Growth

Margins and earnings power

Revenue (TTM)
$92.01M
25106.70% YoY
Profit Margin (TTM)
-194.74%
Operating Margin (TTM)
-2037.16%
Gross Profit (TTM)
-$145.10M
Gross Margin -157.70%
EBITDA (TTM)
-$188.89M
EBITDA Margin -205.30%
Net Income (TTM)
-$179.18M

Efficiency Performance Matrix

4-quadrant analysis of operational efficiency vs profitability

Efficiency vs Profitability Quadrants

High Efficiency
High Margin
High Efficiency
Low Margin
Low Efficiency
High Margin
Low Efficiency
Low Margin

Efficiency Analysis

Asset Turnover
Efficiency:0.16x
Margin:-157.7%
Quadrant:Weak Operations
Receivables Turnover
Efficiency:N/A
Margin:-2037.2%
Quadrant:Unknown
Working Capital
Efficiency:0.25x
Margin:-194.7%
Quadrant:Weak Operations
Overall Efficiency Score

Operationally weak with structural efficiency and margin issues

⚠️ Thresholds are benchmark-based heuristics derived from long-term industry averages, not strict valuation rules.

• Bubble size represents ROIC magnitude

• Green (Optimal): Excellent efficiency-profitability balance

• Blue (Efficiency-Driven): High turnover, room to improve margins

• Yellow (Margin-Driven): Strong margins, opportunity to improve efficiency

• Red (Weak Operations): Areas needing improvement on both dimensions

Market Data & Share Structure

Comprehensive valuation metrics and ownership breakdown

Market Data & Capitalization

Market Cap
$723.70M
Small-cap: Higher growth potential, increased volatility
Enterprise Value
$401.58M
EV 45% < Market Cap: Net cash position
Next Earnings Date
11/10/2026
Scheduled quarterly results announcement

Share Statistics & Ownership

Shares Outstanding
55.24M
Total shares issued and held by all shareholders
Shares Float
42.55M
77% float - restricted shares held
Institutional Ownership
N/A
Held by funds, pensions, endowments
Insider Ownership
2.72%
Moderate alignment - typical for large-cap
Shares Short
11.24M
26.4% of float - high short interest
Implied Shares Outstanding
55.24M
Matches reported shares - consistent data

Profitability Margin Pyramid

Hierarchical view of margin compression from revenue to net income

Margin Hierarchy by Profitability Level

100.0%
Revenue
$92.01M
-157.7%
Gross Profit
-$145.10M
-205.3%
EBITDA
-$188.89M
-194.7%
Net Income
-$179.18M
Margin Profile:
Revenue— 100.0% margin (Top line revenue generation)
Gross Profit— -157.7% margin (Revenue minus cost of goods sold)
EBITDA— -205.3% margin (Earnings before interest, taxes, depreciation, and amortization)
Net Income— -194.7% margin (Bottom line profitability after all expenses)

Margin Analysis

Total Revenue

Amount:$92.01M
Margin:100.0%
Top line revenue generation

Gross Profit

Amount:-$145.10M
Margin:-157.7%
Revenue minus cost of goods sold

EBITDA

Amount:-$188.89M
Margin:-205.3%
Earnings before interest, taxes, depreciation, and amortization

Net Income

Amount:-$179.18M
Margin:-194.7%
Bottom line profitability after all expenses

Margin Quality Assessment

Thin margins indicating potential profitability challenges

• Larger circles represent higher dollar amounts

• Margin percentages show profitability at each level

• Blue: Revenue base

• Green: Gross profitability

• Yellow: Operating performance

• Red: Net profitability

Operating Cash & Liquidity

Core cash generation and short-term solvency

Cash Flow Analysis

Operating Cash Flow (TTM)

-$156.07M

Cash from core operations

Free Cash Flow (TTM)

-$156.18M

Available after capex

Financial Position & Liquidity

Current Ratio

8.03

Healthy

Quick Ratio

7.68

Strong

Net Cash

$322.12M

Net creditor

Total Cash

$361.33M

Balance sheet cash

Total Debt

$39.22M

Outstanding borrowings

Ownership & Shareholder Sentiment

Insider, institutional, and short interest positions

Insider Ownership

2.72%

Moderate stake

Short % of Float

23.32%

Heavy bearish

Short Ratio (Days)

11.6d

days to cover

Ownership structure shows limited insider stake and mixed institutional participation.

Dividends & Shareholder Returns

Policy stance and implications

The company does not currently pay a regular dividend — prioritizing reinvestment for growth. This makes it attractive for growth investors, while income-oriented investors may prefer peers with dividend payouts.

Trailing Dividend Rate
0
Trailing Dividend Yield
0.00%
Forward Annual Dividend Yield
0.00%